Pharmaceutical therapies for OSA, weight loss and residual sleepiness - Amsterdam 2025

PG10 PG10 Update on the treatment concepts for obstructive sleep apnoea -

Chair(s): Esther Irene Schwarz, Elisa Perger

Session type: Postgraduate course

Pharmaceutical therapies for OSA, weight loss and residual sleepiness

Dries Testelmans

EVENTS HOME

Replay
Slides

Previous presentation

Next presentation

Session content

Continuous positive airway pressure: implementation and follow-up strategies integrating new technologies

Manuel Sanchez De La Torre

Replay

Slides

Discussion and Q&A

Patient selection, outcomes and current gaps for the implementation of non-continuous positive airway pressure treatments

Athanasia Pataka

Replay

Slides

Discussion and Q&A

Pharmaceutical therapies for OSA, weight loss and residual sleepiness

Dries Testelmans

Replay

Slides

Discussion and Q&A

Break

Successful therapy and important outcomes in OSA: the patients and physicians perspectives

Stefania Redolfi

Elisa Perger

Replay

Slides - Redolfi

Slides - Perger

Discussion and Q&A

Group assignment

Athanasia Pataka

Stefania Redolfi

Replay

Slides - Redolfi

Slides - Pataka

Session aims

to discuss the available treatment options for obstructive sleep apnoea (OSA); to explain the indications, advantages and drawbacks of these different treatment concepts; to discuss the appropriate selection of different treatment modalities; to explain successful therapy and important outcomes of OSA treatment from the patient's and physician's perspectives.

CDN Connection Issue

The ERS Congress 2025, Amsterdam

#{title}